[Treatment of parkinsonian tremors with the beta-adrenalytic agent KL 255].
D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*; D010301:Parkinson Disease, Postencephalitic / Q000188:drug therapy; D013565:Sympatholytics / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D014202:Tremor / Q000188:drug therapy*
D013565:Sympatholytics
Die Behandlung des Parkinsontremors mit dem Beta-Adrenolytikum KL 255.